Coronavirus spike proteins in viral entry and pathogenesis - PubMed (original) (raw)

Review

Coronavirus spike proteins in viral entry and pathogenesis

T M Gallagher et al. Virology. 2001.

No abstract available

PubMed Disclaimer

Similar articles

Cited by

References

    1. Baric R.S., Yount B., Hensley L., Peel S.A., Chen W. Episodic evolution mediates interspecies transfer of a murine coronavirus. J. Virol. 1997;71:1946–1955. - PMC - PubMed
    1. Dveksler G.S., Pensiero M.N., Dieffenbach C.W., Cardellichio C.B., Basole A.A., Elia P.E., Holmes K.V. Mouse hepatitis virus strain A59 and blocking antireceptor monoclonal antibody bind to the N-terminal domain of cellular receptor. Proc. Natl. Acad. Sci. USA. 1993;90:1716–1720. - PMC - PubMed
    1. Fazakerley J.K., Parker S.E., Bloom F., Buchmeier M.J. The V5A13.1 envelope glycoprotein deletion mutant of mouse hepatitis virus type 4 is neuroattenuated by its reduced rate of spread in the central nervous system. Virology. 1992;187:178–188. - PMC - PubMed
    1. Gallagher T.M. A role for naturally occurring variation of the murine coronavirus spike protein in stabilizing association with the cellular receptor. J. Virol. 1997;71:3129–3137. - PMC - PubMed
    1. Gallagher T.M., Escarmis C., Buchmeier M.J. Alteration of the pH dependence of coronavirus-induced cell fusion: Effect of mutations in the spike glycoprotein. J. Virol. 1991;65:1916–1928. - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources